- Home
- RMBL vs IMAB Comparison
RMBL vs IMAB Comparison
Compare RMBL & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- IMAB
- Stock Information
- Founded
- RMBL 2013
- IMAB 2014
- Country
- RMBL United States
- IMAB United States
- Employees
- RMBL N/A
- IMAB N/A
- Industry
- RMBL EDP Services
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- IMAB Health Care
- Exchange
- RMBL Nasdaq
- IMAB Nasdaq
- Market Cap
- RMBL 90.1M
- IMAB 73.9M
- IPO Year
- RMBL N/A
- IMAB 2020
- Fundamental
- Price
- RMBL $2.23
- IMAB $0.90
- Analyst Decision
- RMBL Hold
- IMAB Strong Buy
- Analyst Count
- RMBL 4
- IMAB 2
- Target Price
- RMBL $4.50
- IMAB $5.50
- AVG Volume (30 Days)
- RMBL 112.8K
- IMAB 97.4K
- Earning Date
- RMBL 05-07-2025
- IMAB 04-03-2025
- Dividend Yield
- RMBL N/A
- IMAB N/A
- EPS Growth
- RMBL N/A
- IMAB N/A
- EPS
- RMBL N/A
- IMAB N/A
- Revenue
- RMBL $1,146,100,000.00
- IMAB N/A
- Revenue This Year
- RMBL N/A
- IMAB N/A
- Revenue Next Year
- RMBL $8.46
- IMAB N/A
- P/E Ratio
- RMBL N/A
- IMAB N/A
- Revenue Growth
- RMBL N/A
- IMAB N/A
- 52 Week Low
- RMBL $1.95
- IMAB $0.60
- 52 Week High
- RMBL $7.06
- IMAB $2.00
- Technical
- Relative Strength Index (RSI)
- RMBL 39.95
- IMAB 53.54
- Support Level
- RMBL $2.06
- IMAB $0.85
- Resistance Level
- RMBL $2.68
- IMAB $0.94
- Average True Range (ATR)
- RMBL 0.22
- IMAB 0.07
- MACD
- RMBL 0.01
- IMAB 0.00
- Stochastic Oscillator
- RMBL 21.79
- IMAB 59.37
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).